2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
7
Malnutrition
5
Pancreatic Neoplasms
3
Stomach Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Cachexia
2
Weight Loss
1
Postoperative Complications
1
Pancreatitis, Chronic
1
Nutritional Support
1
Neoplasms, Plasma Cell
1
Nasopharyngeal Carcinoma
1
Muscular Atrophy
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Infections
1
Hyperphagia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Deglutition Disorders
1
Critical Illness
1
Cholangiocarcinoma
1
Child Nutrition Disorders
1
Interventions
Irinotecan
10
Fluorouracil
10
Leucovorin
9
Bevacizumab
9
Gemcitabine
8
Paclitaxel
7
Cisplatin
7
Capecitabine
7
Oxaliplatin
6
130-nm albumin-bound paclitaxel
6
Albumin-Bound Paclitaxel
5
napabucasin
4
Sorafenib
4
Drug Therapy
4
Cetuximab
4
pembrolizumab
3
apatinib
3
Radiotherapy
3
Ocoxin
3
Imatinib Mesylate
3
Folfox protocol
3
Everolimus
3
tislelizumab
2
spartalizumab
2
palbociclib
2
entinostat
2
encorafenib
2
camrelizumab
2
anlotinib
2
Sunitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
Enteral Nutrition
×
Clear all
NCT03117348
2020-09-22
GIGENAS
Jinling Hospital, China
Phase NA
Completed
411 enrolled